Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.615 USD | -3.58% |
|
-5.29% | +5.23% |
06-21 | Sector Update: Health Care Stocks Gain in Late Afternoon | MT |
06-21 | Lexicon Pharmaceuticals Resubmits New Drug Application for Potential Type 1 Diabetes Therapy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.23% | 605M | |
+16.37% | 122B | |
+17.52% | 114B | |
+19.62% | 25.71B | |
-25.80% | 19.02B | |
-20.21% | 15.83B | |
-20.35% | 15.32B | |
-47.37% | 14.88B | |
+59.97% | 14.82B | |
+4.84% | 14.1B |
- Stock Market
- Equities
- LXRX Stock
- News Lexicon Pharmaceuticals, Inc.
- Transcript : Lexicon Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 02, 2024